Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial
Not Applicable
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003007
- Lead Sponsor
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Meet the diagnostic criteria of the New Coronavirus Pneumonia Diagnosis and Treatment Scheme, patients with pneumonia confirmed by new coronavirus infection;
2. Pneumonia Severity Index (PSI) grade is I ~ II;
3. Aged 18-80 years;
4. Those who have signed the informed consent voluntarily.
Exclusion Criteria
1. People with allergies and allergies to experimental drugs;
2. Combined with other malignant tumors;
3. Patients with hematological diseases, coagulopathy and autoimmune diseases;
4. Combined with severe cardiovascular diseases, Patients with vascular disease, hematopoietic system disease, and neuropathy;
5. Participated in other clinical researchers 3 months before the trial.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood gas analysis;Traditional Chinese medicine syndrome score;Antipyretic time;Pharyngeal swab nucleic acid negative time;
- Secondary Outcome Measures
Name Time Method